Jasper Therapeutics Inc Financial Flexibility Index
Jasper Therapeutics Inc financial flexibility index. Jasper Therapeutics Inc (JSPR) has a Financial Flexibility Index of -0.67x as of June 2026. Free cash flow of $-6.92 Million (operating CF $-6.92 Million minus capex $0.00) represents -1% of total liabilities ($10.39 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Jasper Therapeutics Inc (2019–2025)
Financial flexibility index of Jasper Therapeutics Inc from 2019 to 2025. Historical Financial Flexibility Index trend for Jasper Therapeutics Inc across 7 annual periods. Check Jasper Therapeutics Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Jasper Therapeutics Inc Financial Flexibility Index by Year (2019–2025)
Jasper Therapeutics Inc financial flexibility index by year from 2019 to 2025. Year-by-year free cash flow to debt coverage for Jasper Therapeutics Inc. For the full cash flow conversion analysis, see Jasper Therapeutics Inc (JSPR) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.44x | $-77.15 Million | $-77.16 Million | $31.63 Million | ▲ +28.4% |
| 2024 | -3.40x | $-62.05 Million | $-62.60 Million | $18.23 Million | ▼ -8.1% |
| 2023 | -3.15x | $-51.80 Million | $-52.07 Million | $16.45 Million | ▲ +14.0% |
| 2022 | -3.66x | $-45.28 Million | $-45.86 Million | $12.37 Million | ▼ -182.7% |
| 2021 | -1.29x | $-31.25 Million | $-33.68 Million | $24.14 Million | ▼ -378.1% |
| 2020 | -0.27x | $-15.84 Million | $-18.27 Million | $58.49 Million | ▼ -460.4% |
| 2019 | 0.08x | $459.00K | $-1.97 Million | $6.11 Million | — |